|  United States District Court Judge Amit P. Mehta ruled in favor of three major pharmaceutical companies Monday evening, blocking the Trump administration's final rule to disclose prescription drug list prices in direct-to-consumer television advertisements.
The plaintiffs in the case included three large drugmakers: Merck & Co., Eli Lilly and Co., Amgen Inc., as well as the Association of National Advertisers, Inc.
The decision came one day before the rule, which was finalized in early May, was set to go into effect.
Judge Mehta granted the plaintiff's motion to stay the final rule's effectiveness, writing that the Social Security Act does not authorize HHS to require wholesale drug prices from pharmaceutical companies.
The ruling is likely to be challenged by HHS. Read the full story... | 
